Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa A. Sperling, Gary Romano, David Henley et al.|JAMA Neurology|2021Cited by 110
Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum DiscussionRajeshwari Sridhara, Bruce Binkowitz, Martin Posch et al.|Statistics in Biopharmaceutical Research|2021Cited by 12